---
title: "Rocket One Q2 net loss widens 74.4% to USD 3.84 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295970920.md"
description: "Rocket One reported a Q2 net loss of USD 3.84 million, widening 74.4% from the prior year's USD 2.2 million loss. The increase was driven by higher R&D spending on HT-001 manufacturing and clinical activities, as well as a 62% rise in G&A costs due to stock-based compensation. Cash reserves stood at USD 7.89 million, with USD 6.02 million used in operations. The company is shifting strategy toward AI infrastructure and next-generation semiconductors while continuing drug candidate development."
datetime: "2026-08-14T20:14:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295970920.md)
  - [en](https://longbridge.com/en/news/295970920.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295970920.md)
generator: "portal-rs"
---

# Rocket One Q2 net loss widens 74.4% to USD 3.84 million

-   Rocket One posted a Q2 net loss of USD 3.84 million, or USD 0.19 per share, versus a USD 2.2 million loss. \* R&D spending climbed to USD 1.96 million from USD 1.04 million, driven mainly by HT-001 manufacturing and clinical activities. \* G&A costs rose 62% to USD 1.88 million, largely on higher stock-based compensation tied to stock option issuances. \* Cash and cash equivalents totaled USD 7.89 million at June 30, 2026; net cash used in operations was USD 6.02 million. \* Strategy shifted toward AI infrastructure and next-generation semiconductors, while continuing development of Hoth Therapeutics drug candidates. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rocket One Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-090048), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RKTO.US](https://longbridge.com/en/quote/RKTO.US.md)

## Related News & Research

- [Rocket One Launches Swarm Stage AI Drone-Swarm Threat Emulation Platform for U.S. Military Counter-UAS](https://longbridge.com/en/news/296226492.md)
- [Rocket One ups ATM equity offering by additional $5.26 million](https://longbridge.com/en/news/294550821.md)
- [The Rocket Is Only 1 Piece of Rocket Lab’s Real Strategy](https://longbridge.com/en/news/296396212.md)
- [Rocket Doctor AI grants 24,000 stock options at $0.70 per share to consultants](https://longbridge.com/en/news/296828526.md)
- [GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy](https://longbridge.com/en/news/296748151.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**